HEOR
Health economics & outcomes research.
The discipline that translates clinical evidence into the cost-effectiveness, budget impact and value arguments HTA bodies and payers actually buy.
Health economics and outcomes research (HEOR) sits at the intersection of clinical evidence, economic modelling and patient-reported outcomes. The HEOR function builds the cost-effectiveness model, the budget impact analysis, and the indirect comparisons that anchor your value story for HTA and payer audiences.
A one-pager deck template for investor and BD conversations — anchored in HTA precedent, comparator landscape, pricing corridor and BD comparables.
The Series C deck is not a science talk. It is a sequencing argument. Here is the eight-slide spine the strongest decks share — and the numbers behind each one.
A continuously refreshed launch-readiness map — competitor pipeline, HTA precedent, payer mix, KOLs, RWE and field readiness.